Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

NANot yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2026

Conditions
Portal Vein Thrombosis
Interventions
PROCEDURE

TIPS

Using the transjugular approach, TIPS was created under local anesthesia. The first branch of the left or right portal vein (PV) was punctured by RUPS-100 set guided by digital subtraction angiography. After successful access into PV, direct portography was performed and all visible varices and/or concurrent spontaneous portosystemic shunts (SPSS) were embolized with coils and n-butyl cyanoacrylate. A polytetrafluoroethylene-covered stent (Viatorr Endoprosthesis, GORE and Associates, Flagstaff, Arizona, USA) with a diameter of 8 mm was implanted and fully dilated.

DRUG

Nadroparin

Nadroparin calcium will be subcutaneously injected with the dose of 85IU/kg q12h

All Listed Sponsors
collaborator

Shanghai 6th People's Hospital

OTHER

collaborator

ShuGuang Hospital

OTHER

collaborator

Tongji Hospital

OTHER

collaborator

Renmin Hospital of Wuhan University

OTHER

lead

Shanghai Zhongshan Hospital

OTHER

NCT06319131 - Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT | Biotech Hunter | Biotech Hunter